We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+261.51%
AUM
$604M
AUM Growth
+$33.6M
Cap. Flow
-$19.5M
Cap. Flow %
-3.23%
Top 10 Hldgs %
28.56%
Holding
910
New
70
Increased
175
Reduced
194
Closed
71

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$7.06M
2
VST icon
Vistra
VST
+$5.44M
3
EOG icon
EOG Resources
EOG
+$5.13M
4
STZ icon
Constellation Brands
STZ
+$4.88M
5
BEN icon
Franklin Resources
BEN
+$3.8M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$8.49M
2
PEP icon
PepsiCo
PEP
+$6.38M
3
T icon
AT&T
T
+$5.27M
4
CVS icon
CVS Health
CVS
+$5.09M
5
BMY icon
Bristol-Myers Squibb
BMY
+$4.4M

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 13.6%
3 Financials 11.15%
4 Consumer Staples 6.76%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
801
Zymeworks
ZYME
$1.73B
$1K ﹤0.01%
25
-25
-50% -$908
NPKI
802
NPK International
NPKI
$1.15B
$1K ﹤0.01%
228
BSCO
803
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$1K ﹤0.01%
50
NVTA
804
DELISTED
Invitae Corporation
NVTA
$1K ﹤0.01%
+60
New +$1.06K
LTHM
805
DELISTED
Livent Corporation
LTHM
$1K ﹤0.01%
173
GHL
806
DELISTED
Greenhill & Co., Inc.
GHL
$1K ﹤0.01%
+65
New +$1.05K
ZYNE
807
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1K ﹤0.01%
165
PRTK
808
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
+275
New +$954
TA
809
DELISTED
TravelCenters of America LLC
TA
$1K ﹤0.01%
60
ATCX
810
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$1K ﹤0.01%
100
SWCH
811
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$1K ﹤0.01%
+50
New +$758
ZEN
812
DELISTED
ZENDESK INC
ZEN
$1K ﹤0.01%
10
RDS.B
813
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1K ﹤0.01%
17
RPAI
814
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$1K ﹤0.01%
78
XEC
815
DELISTED
CIMAREX ENERGY CO
XEC
$1K ﹤0.01%
20
CHMA
816
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1K ﹤0.01%
250
GWPH
817
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1K ﹤0.01%
+10
New +$1.12K
AIG.WS
818
DELISTED
American International Group, Inc.
AIG.WS
$1K ﹤0.01%
82
BMY.RT
819
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1K ﹤0.01%
+325
New +$845
AMAG
820
DELISTED
AMAG Pharmaceuticals
AMAG
$1K ﹤0.01%
84
IMMU
821
DELISTED
Immunomedics Inc
IMMU
$1K ﹤0.01%
+60
New +$1.06K
AMTD
822
DELISTED
TD Ameritrade Holding Corp
AMTD
$1K ﹤0.01%
21
-79
-79% -$3.42K
BFYT
823
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$1K ﹤0.01%
30
BGG
824
DELISTED
Briggs & Stratton Corp.
BGG
$1K ﹤0.01%
112
I
825
DELISTED
INTELSAT S. A.
I
$1K ﹤0.01%
150
-17,150
-99% -$270K

Similar funds

Howe & Rusling's Q4 2019 Portfolio in Review

As of Q4 2019, Howe & Rusling held 910 positions worth $604M, up 5.9% from $571M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Howe & Rusling withdrew a net $19.5M in Q4 2019, closing 71 positions and reducing 194 holdings. Its most notable exit was SunTrust Banks, Inc., an estimated $2.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Howe & Rusling opened a new position in Truist Financial worth $2.66M.

  • Howe & Rusling's largest Q4 2019 buy was Truist Financial: 47,160 shares worth $2.66M.
  • Howe & Rusling added most to ExxonMobil in Q4 2019, an estimated $7.06M increase.
  • Howe & Rusling's biggest Q4 2019 reduction was 3M, cutting an estimated $8.49M.
  • Howe & Rusling fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $2.52M.
  • Howe & Rusling's ten largest holdings make up 29% of its $604M portfolio in Q4 2019.
  • Howe & Rusling opened 70 new positions and closed 71 in Q4 2019.
  • Howe & Rusling's portfolio value rose 5.9% quarter-over-quarter to $604M.

Based on Howe & Rusling's 13F filing for Q4 2019, filed 5 Feb 2020.